HealthcareServices

Viscosupplementation Treatment For Arthritis Market Forecast: How Big Will It Be by 2030?

March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the viscosupplementation treatment for arthritis market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Viscosupplementation Treatment For Arthritis Market expected to reach by 2030?

The viscosupplementation treatment for arthritis market size has demonstrated significant expansion in recent years. It is forecast to grow from $4.18 billion in 2025 to $4.5 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.7%. Historically, this market’s expansion can be ascribed to factors including the escalating prevalence of osteoarthritis, an expanding aging demographic, the early clinical adoption of hyaluronic acid injections, the evolution of orthopedic treatment practices, and the increased availability of injectable joint therapies.

The viscosupplementation treatment for arthritis market is projected to experience robust expansion in the coming years. It will grow to $5.98 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.4%. This anticipated growth during the forecast period is attributable to several factors, including a heightened demand for non-invasive arthritis therapies, an increase in healthcare spending dedicated to musculoskeletal conditions, the broadening of outpatient orthopedic provisions, a greater emphasis on enhancing patients’ quality of life, and continuous advancements in viscosupplement formulations. Key trends anticipated over this period involve the increasing embrace of single-injection treatment protocols, a surging need for enduring pain alleviation options, the proliferation of minimally invasive arthritis interventions, a concentrated effort on developing superior joint lubrication compositions, and a heightened focus on patient-centered therapeutic methods.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30433&type=smp

What Drivers Are Driving Adoption Within The Viscosupplementation Treatment For Arthritis Market?

The rising incidence of osteoarthritis is projected to stimulate the expansion of the viscosupplementation treatment for the arthritis market. Osteoarthritis is defined as a persistent joint condition characterized by the progressive deterioration of cartilage, leading to discomfort, rigidity, and limited movement. The growing occurrence of osteoarthritis largely stems from an aging demographic, as the natural wear and tear on joints over time makes older adults more vulnerable to this ailment. Viscosupplementation treatment for arthritis assists in managing osteoarthritis by restoring joint lubrication, alleviating pain, and enhancing mobility. For instance, in February 2025, Springer Nature Group, a UK-based academic and professional publishing company, calculated knee osteoarthritis cases to be 12.94 million in males and 18.80 million in females. By 2046, these figures are anticipated to climb to 18.45 million in males and 25.60 million in females. Consequently, the increasing prevalence of osteoarthritis is propelling the growth of the viscosupplementation treatment for the arthritis market.

What Segments Are Included Within The Viscosupplementation Treatment For Arthritis Market?

The viscosupplementation treatment for arthritis market covered in this report is segmented –

1) By Product Type: Single Injection, Three Injections, Five Injections

2) By Application: Knee Osteoarthritis, Hip Osteoarthritis, Shoulder Osteoarthritis, Other Applications

3) By End-User: Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics, Other End-Users

Subsegments:

1) By Single Injection: High Molecular Weight Hyaluronic Acid, Low Molecular Weight Hyaluronic Acid, Cross-Linked Hyaluronic Acid

2) By Three Injections: Standard Hyaluronic Acid, Buffered Hyaluronic Acid, Biofermented Hyaluronic Acid

3) By Five Injections: Cross-Linked High Viscosity Hyaluronic Acid, Extended-Release Hyaluronic Acid, Multi-Dose Hyaluronic Acid

Which Market Trends Are Opening Growth Opportunities In The Viscosupplementation Treatment For Arthritis Market?

Leading companies active in the viscosupplementation treatment for the arthritis market are prioritizing the creation of innovative solutions, such as advanced hyaluronic acid formulations, to improve joint lubrication, lessen pain, and boost mobility. These sophisticated hyaluronic acid formulations are specifically engineered variants of hyaluronic acid, featuring an enhanced molecular structure and viscosity, designed to deliver more enduring joint lubrication and more potent pain relief in arthritis treatment. For instance, in February 2024, IBSA Group, a pharmaceutical firm based in Switzerland, unveiled the SINOVIAL range, a next-generation viscosupplementation treatment intended for musculoskeletal conditions. This range harnesses advanced NAHYCO technology, which merges high and low molecular weight hyaluronic acid to provide effective joint lubrication and extended pain relief. Developed to emulate the functions of natural synovial fluid, these treatments bolster joint cushioning and shock absorption. The injectable formulation offers optimal viscosity and exceptional tolerance, aiding in improved patient comfort, enhanced mobility, and better management of osteoarthritis and various other musculoskeletal disorders.

Who Are The Prominent Global Companies Shaping The Viscosupplementation Treatment For Arthritis Market Landscape?

Major companies operating in the viscosupplementation treatment for arthritis market are Johnson And Johnson, Sanofi S.A., LG Chem Ltd., Teva Pharmaceutical Industries Ltd., Chugai Pharmaceutical Co. Ltd., Zimmer Biomet Holdings Inc., IBSA Group, Bioventus Inc., Fidia Farmaceutici S.p.A., Ferring Pharmaceuticals A/S, Anika Therapeutics Inc., TRB Chemedica International S.A., Laboratoires VIVACY, Seikagaku Corporation, Regen Lab SA, Genzyme Corporation, Medtronic PLC, Orthogenix Inc., Hyundai Pharm Co. Ltd., DePuy Synthes

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/global-viscosupplementation-treatment-for-arthritis-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Viscosupplementation Treatment For Arthritis Market?

North America was the largest region in the viscosupplementation treatment for arthritis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viscosupplementation treatment for arthritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Viscosupplementation Treatment For Arthritis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30433&type=smp

Browse Through More Reports Similar to the Global Viscosupplementation Treatment For Arthritis Market 2026, By The Business Research Company

Rheumatoid Arthritis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report

Rheumatology Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/rheumatology-therapeutics-global-market-report

Canine Arthritis Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795